Envestnet Asset Management’s Guardant Health GH Stock Holding History

Envestnet Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.73M	Buy	64,823 +13,924	+27%	+$1.51M	﹤0.01%	1976
2026 Q1	$4.7M	Buy	50,899 +20,062	+65%	+$2.01M	﹤0.01%	2356
2025 Q4	$3.15M	Sell	30,837 -10,894	-26%	-$975K	﹤0.01%	2506
2025 Q3	$2.61M	Buy	41,731 +3,109	+8%	+$169K	﹤0.01%	2712
2025 Q2	$2.01M	Buy	38,622 +11,125	+40%	+$497K	﹤0.01%	2819
2025 Q1	$1.17M	Buy	27,497 +15,877	+137%	+$685K	﹤0.01%	3098
2024 Q4	$355K	Sell	11,620 -2,060	-15%	-$58K	﹤0.01%	3790
2024 Q3	$314K	Buy	13,680 +2,192	+19%	+$62K	﹤0.01%	3797
2024 Q2	$332K	Sell	11,488 -20,656	-64%	-$481K	﹤0.01%	3669
2024 Q1	$663K	Sell	32,144 -128,836	-80%	-$2.76M	﹤0.01%	3273
2023 Q4	$4.35M	Sell	160,980 -9,754	-6%	-$256K	﹤0.01%	1991
2023 Q3	$5.06M	Buy	170,734 +114,128	+202%	+$4.01M	﹤0.01%	1791
2023 Q2	$2.03M	Buy	56,606 +9,788	+21%	+$281K	﹤0.01%	2270
2023 Q1	$1.1M	Sell	46,818 -412	-0.9%	-$11.8K	﹤0.01%	2602
2022 Q4	$1.28M	Sell	47,230 -11,783	-20%	-$539K	﹤0.01%	2464
2022 Q3	$3.18M	Buy	59,013 +16,552	+39%	+$850K	﹤0.01%	1799
2022 Q2	$1.71M	Buy	42,461 +386	+0.9%	+$19.1K	﹤0.01%	2212
2022 Q1	$2.79M	Sell	42,075 -14,811	-26%	-$1.01M	﹤0.01%	1999
2021 Q4	$5.69M	Sell	56,886 -14,939	-21%	-$1.55M	﹤0.01%	1524
2021 Q3	$8.98M	Buy	71,825 +3,575	+5%	+$425K	﹤0.01%	1205
2021 Q2	$8.48M	Buy	68,250 +2,912	+4%	+$392K	﹤0.01%	1232
2021 Q1	$9.97M	Buy	65,338 +10,537	+19%	+$1.59M	0.01%	1035
2020 Q4	$7.06M	Buy	54,801 +7,679	+16%	+$884K	0.01%	1106
2020 Q3	$5.27M	Buy	47,122 +568	+1%	+$52K	﹤0.01%	1140
2020 Q2	$3.78M	Buy	46,554 +2,262	+5%	+$182K	﹤0.01%	1260
2020 Q1	$3.08M	Buy	44,292 +40,582	+1,094%	+$3.11M	﹤0.01%	1222
2019 Q4	$290K	Sell	3,710 -364	-9%	-$26.2K	﹤0.01%	2750
2019 Q3	$260K	Buy	+4,074	New	+$359K	﹤0.01%	2739

Other funds holding GH

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Envestnet Asset Management's GH Position: Q2 2026 in Review

Envestnet Asset Management increased its Guardant Health (GH) stake by 27% in Q2 2026, buying an estimated $1.51M and bringing the position to 64,823 shares worth $9.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1976.

Envestnet Asset Management first reported a position in GH in Q3 2019 and has held it in 28 quarters since. The position peaked at $9.97M in Q1 2021. 211 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Envestnet Asset Management held 64,823 shares of Guardant Health worth $9.73M as of Q2 2026.
Envestnet Asset Management bought 13,924 Guardant Health shares in Q2 2026, an estimated $1.51M.
Guardant Health made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1976 holding.
Envestnet Asset Management first reported a position in Guardant Health in Q3 2019 and has held it in 28 quarters since.
Envestnet Asset Management's Guardant Health position peaked at $9.97M in Q1 2021.
211 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.